PuSH - Publication Server of Helmholtz Zentrum München

121 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
101.
Kronenberg, F.* & Heid, I.M.: Genetik intermediärer Phänotypen. Med. Genet. 19, 304-308 (2007)
102.
Schoenborn, V.* et al.: Sample selection algorithm to improve quality of genotyping from plasma-derived DNA: To separate the wheat from the chaff. Hum. Mutat. 28, 1141-1149 (2007)
103.
Vollmert, C. et al.: Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians. Am. J. Physiol. Endocrinol. Metab. 292, E836-E844 (2007)
104.
Kollerits, B.* et al.: Lipoprotein(a) as a predictor of cardiovascular disease in a prospectively followed cohort of patients with type 1 diabetes. Diabetes Care 29, 1661-1663 (2006)
105.
Lamina, C. et al.: Association of ankle-brachial index and plaques in the carotid and femoral arteries with cardiovascular events and total mortality in a population-based study with 13 years of follow-up. Eur. Heart J. 27, 2580-2587 (2006)
106.
Lingenhel, A.* et al.: Role of the kidney in the metabolism of apolipoprotein A-IV: Influence of the type of proteinuria. J. Lipid Res. 47, 2071-2079 (2006)
107.
Mackevics, V.* et al.: The adiponectin gene is associated with adiponectin levels but not with characteristics of the insulin resistance syndrome in healthy Caucasians. Eur. J. Hum. Genet. 14, 349-356 (2006)
108.
Schoenborn, V.* et al.: The ATGL gene is associated with free fatty acids, triglycerides and type 2 diabetes. Diabetes 55, 1270-1275 (2006)
109.
Schwaiger, J.P.* et al.: Carotid plaques and their predictive value for cardiovascular disease and all-cause mortality in hemodialysis patients considering renal transplantation: A decade follow-up. Am. J. Kidney Dis. 47, 888-897 (2006)
110.
Haiman, M.* et al.: Immunohistochemical localization of apolipoprotein A-IV in human kidney tissue. Kidney Int. 68, 1130-1136 (2005)
111.
Heid, I.M. et al.: Wie gut können Haplotypen in den populationsbasierten KORA-Studien rekonstruiert werden? Gesundheitswesen 67, (Sonderheft 1), 132-136 (2005)
112.
Ikewaki, K.* & Kronenberg, F.: Delayed in Vivo Catabolism of Intermediate-Density Lipoprotein and Low-Density Lipoprotein in Hemodialysis Patients as Potential Cause of Premature Atheriosclerosis. Arterioscler. Thromb. Vasc. Biol. 25, 2615-2622 (2005)
113.
Lamina, C. et al.: Ankle-Brachial index and peripheral arterial disease. Gesundheitswesen 67, (Sonderheft 1), 57-61 (2005)
114.
Frauscher, B.* et al.: Association of daytime sleepiness with COMT polymorphism in patients with Parkinson disease: A pilot study. Sleep 27, 733-736 (2004)
115.
Kronenberg, F. et al.: Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy? Kidney Int. 66, 348-354 (2004)
116.
Kronenberg, F. et al.: The apolipoprotein(a) size polymorphism is associated with nephrotic syndrome. Kidney Int. 65, 606-612 (2004)
117.
Kronenberg, F.: Epidemiology, pathophysiology and therapeutic implications of lipoprotein(a) in kidney disease. Expert Rev. Cardiovasc. Ther. 2, 729-743 (2004)
118.
Lingenhel, A.* et al.: Decrease of plasma apolipoprotein A-IV during weight reduction in obese adolescents on a low fat diet. Int. J. Obes. 28, 1509-1513 (2004)
119.
Rantner, B.* & Kronenberg, F.: Reverse Epidemiologie bei nephrologischen Patienten: Paradoxe Risikofaktoren für Mortaliät und Atherosklerose. J. Hyperton. 8, 21-29 (2004)
120.
Kronenberg, F. et al.: Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients. Kidney Int. 63, Suppl.84, 113-116 (2003)